Fugro N.V. (FUR)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 7.360 |
|---|---|
| 52-week range | 6.990 – 12.840 |
| Return, 1 month / 3 months | −7.7% / −24.8% |
| Return, 1 year / 3 years | −17.2% / −41.2% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 36.6% |
| Worst drawdown (1 year) | -43.0% |
| Average daily value traded | 3.28M EUR |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fugro is a Dutch company that gathers and interprets data about the earth and the seabed for clients in energy, infrastructure and water management. It carries out geotechnical and geophysical surveys, site characterisation and subsea inspection work, using vessels, drilling rigs, remote sensing and laboratory testing. Its customers include oil and gas operators, offshore wind developers, port and coastal authorities, and construction and engineering firms. Fugro is based in Leidschendam in the Netherlands and works on projects around the world.
Fugro N.V. trades under the code FUR on the Euronext Amsterdam in Netherlands, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fugro N.V. (FUR) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 7.360 on 22 October 2026.
Its price-based Market X-Ray is 24 out of 100 (a weak price profile), ranking 94 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.2% and over the last three months it fell 24.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -26.4% | ||
| From 52-week high | -40.4% | ||
| Momentum | 15 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.8% | ||
| 6-month return | -30.0% | ||
| 12-month return, skipping the last month | -10.3% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.0% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.28M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 13 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.5% |
|---|---|
| 1 month | −7.7% |
| 3 months | −24.8% |
| 6 months | −30.0% |
| 1 year | −17.2% |
| 3 years | −41.2% |
| 5 years | −5.3% |
Signals
| 50-day / 200-day average | 8.172 / 9.997 |
|---|---|
| Golden / death cross (60 days) | Death, 53 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.242 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | EUR 0.1500 |
| 28 Apr 2025 | EUR 0.7500 |
| 29 Apr 2024 | EUR 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.